SCHEMBL3011124

SCHEMBL3011124

Cc1cccc(C)c1Cc1csc(N2CCC(S(=O)(=O)c3cc(Cl)ccc3Cl)CC2)n1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.37
RAB9A P51151 1/20 0.37
RECQL P46063 1/20 0.36
TSHR P16473 3/20 0.35
NPSR1 Q6W5P4 2/20 0.35
HTT P42858 1/20 0.35
POLB P06746 2/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
ALDH1A1 P00352 2/20 0.35
ALDH3A1 P30838 1/20 0.35
CTSS P25774 1/20 0.35
MAPT P10636 2/20 0.34
GAA P10253 2/20 0.34
FBP1 P09467 1/20 0.34
ALOX15 P16050 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
KDM4E B2RXH2 1/20 0.34
CNR1 P21554 2/20 0.33
TDP1 Q9NUW8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3015699 0.93 EPHX2 (0.35) SMN1; SMN2RAB9ARECQLTSHRNPSR1
SCHEMBL3019338 0.93 CTSS (0.38) SMN1; SMN2RAB9AALDH1A1CTSSMAPT
SCHEMBL3013472 0.91 SMN1; SMN2 (0.38) SMN1; SMN2RAB9ARECQLTSHRNPSR1
SCHEMBL3014184 0.91 RECQL (0.38) SMN1; SMN2RAB9ARECQLTSHRNPSR1
SCHEMBL3022762 0.90 LMNA (0.36) SMN1; SMN2RAB9AMEN1KMT2ACTSS
SCHEMBL3016908 0.90 CTSS (0.44) SMN1; SMN2RAB9AMEN1KMT2AALDH1A1
SCHEMBL3016058 0.90 MAPK1 (0.39) SMN1; SMN2RAB9ARECQLTSHRHTT
SCHEMBL3002429 0.88 MAPT (0.44) SMN1; SMN2RECQLTSHRNPSR1HTT
SCHEMBL3018865 0.88 ALDH1A1 (0.39) SMN1; SMN2RAB9ARECQLTSHRNPSR1
SCHEMBL3014628 0.87 CTSS (0.43) SMN1; SMN2RAB9ATSHRMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8722681-B2 N-sulfonyl thiazolylpiperazine derivatives and related N-sulfonyl heterocyclic derivatives for the treatment of neuro degenerative diseases NV REMYND (BE) 2014-05-13 US disclosed
US-20100197703-A1 N-SULFONYL THIAZOLYLPIPERAZINE DERIVATIVES AND RELATED N-SULFONYL HETEROCYCLIC DERIVATIVES FOR THE TREATMENT OF NEURO DEGENERATIVE DISEASES NV REMYND (BE) 2010-08-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100197703-A1 N-SULFONYL THIAZOLYLPIPERAZINE DERIVATIVES AND RELATED N-SULFONYL HETEROCYCLIC DERIVATIVES FOR THE TREATMENT OF NEURO DEGENERATIVE DISEASES SMN1; SMN2, HTT, SNCA SMN1; SMN2 1/4885RAB9A 2943/4885RECQL 1564/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.